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Improving Intermediate Lactate Sepsis Bundle Performance
Abstract
The aim of this project is to improve intermediate sepsis bundle performance with a
primary focus on repeat lactate within 6 hours of arrival in the ED. One of the most significant
problems we are facing today in healthcare, with an incidence of 300 to more than 1,000 cases
per 100,000 persons annually in the United States, is severe sepsis (Gaieski, Edwards, Kalian, &
Carr, 2013). Multiple studies have shown a strong correlation in reducing hospital and 30-day
mortality by implementing process-oriented bundle for patients with sepsis and intermediate
lactate values in accordance with the Surviving Sepsis Campaign guidelines. The site for this
quality improvement project is a not-for-profit, medium-sized, tertiary hospital serving the San
Joaquin and Stanislaus county communities. The improvement team comprised of a CNL
student, physician champions, unit nurse champions, educators, and staff champions from lab,
radiology, and pharmacy. The interventions for this project include, (a) developing a sepsis
screening tool to help frontline nurses recognize early signs of sepsis, (b) developing a
standardized process between lab and nursing for repeat lactate orders, (c) implementing the
sepsis clockvs tool which outlines timely appropriate treatment based on clinical guidelines for
patients diagnosed with sepsis, and (d) implement a sepsis alert protocol to activate early and
appropriate interventions. Results show that use of a screening tool to help identify early signs
of sepsis as well as use of sepsis clock tool which serves as a visual aid for the staff to keep track
of specific timelines increased compliance with the sepsis bundle.
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Introduction
Healthcare delivery in the 21st century continues to evolve to provide world-class quality
of care in order to produce optimal patient outcomes. As care delivery shifts within a
department’s mission to best accommodate and meet the needs of the patient population, it is
imperative for department members to feel empowered in their role as an integral part of the
healthcare delivery team. With the shift in focus from volume to value-based care, much
emphasis is placed on performance improvement, identifying best practices, and transforming
healthcare delivery (Zangerle, Harris, Rimmasch, & Randazzo, 2016).
One of the most significant problems we are facing today in healthcare, with an incidence
of 300 to more than 1,000 cases per 100,000 persons annually in the United States, is severe
sepsis (Gaieski, Edwards, Kalian, & Carr, 2013). The number of critically ill patients presenting
in the ED with sepsis is staggering. According to Hall et al. (2011), the number of patients in the
hospital with a principal diagnosis of sepsis or septicemia has more than doubled from 11.6 in
2000 to 24.0 in 2008 per 10,000 patients with mortality associated with severe sepsis ranging at
30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011). Guidelines for early
identification and treatment of sepsis has been known to decrease sepsis mortality by at least
14% or 12,500 lives saved per year (Moore et al., 2009). In addition, multiple studies have
shown a strong correlation in reducing hospital and 30-day mortality by implementing process-

oriented bundle for patients with sepsis and intermediate lactate values in accordance with the
Surviving Sepsis Campaign guidelines. However, although these bundles are associated with
improved patient outcomes, adherence to these bundles remain to be an area of opportunity
(Ramsdell, Smith, and Kerkhove, 2017).
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Therefore, this project aims to improve intermediate sepsis bundle performance with a
primary focus on repeat lactate within 6 hours of arrival in the ED. The sepsis bundle is
comprised of early recognition and treatment of sepsis which includes: Lactate drawn within one
hr. of ED arrival, appropriate antibiotic administered within 3 hrs. of ED arrival, fluids
administered appropriately within 3 hrs. of ED arrival, and repeat lactate drawn within 6 hrs. of
ED arrival. Harris, Roussell, and Thomas (2014) states that the microsystem is a setting in
which collaborative members of teams have the opportunity to test changes in healthcare
delivery that directly impact patient outcomes. Therefore, this project aims to improve
intermediate sepsis bundle compliance in the ED, thereby reducing sepsis mortality.
Problem Description
The site for this quality improvement project is a not-for-profit, tertiary hospital serving
the San Joaquin and Stanislaus county communities. This medium-sized community hospital is
licensed to operate 152 beds and offers many different services ranging from 24/7 emergency
room, intensive care, medical/surgical/telemetry as well as maternity and pediatrics. The
hospital’s mission is “to provide high quality, affordable health care services and improve the
health of our members and the communities we serve.” Sepsis is the number one top diagnosis
followed by CHF, Major surgery, GI bleed, Stroke, Cancer, Pancreatitis, ESRD, Diabetes, and
Cellulitis. Thirty-nine percent of patients are discharged to home and 36% are discharged to a
skilled nursing facility. The microsystem observed for this study is the ED.
Due to the wide array of diagnoses that this microsystem is often subjected to, teamwork
and collaboration are of up-most importance among the staff members. Therefore, a
multidisciplinary approach is necessary for providing high-quality patient care. Some potential
barriers to change include staff resistance, staff shortage, resources, and trust which can often
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evoke feelings of frustration. Therefore, utilizing the CNL’s skill to build trust, to empower and
influence teamwork is a critical piece in bringing about change. Finkelman (2016) recognized
transformational leadership as one of the most effective styles of leadership in our healthcare
system today. A transformational leader not only rewards but also provides guidance to help
staff work towards a common or shared vision that embraces change and fosters positive work
environments. Based on a review of the data for this microsystem, the sepsis intermediate lactate
bundle performance has been well below the target of 55% for at least 9 out of the past 12
months. The “All or None” bundle is comprised of a minimum of 3 to a maximum of 7
elements. The performance was at times 35 percentage points lower than target. As a result, this
medical center is one of the lowest performers in the region, which warrants a quality
improvement project in order to improve performance with a primary focus on repeat lactate.
Available Knowledge
PICOT Question: Intermediate sepsis bundle
The PICOT question that guided the search for evidence in this project was: For patients
identified with severe sepsis in the ED (P), does increasing compliance with intermediate sepsis
bundle (I) compared to non-adherence to the bundle (C) improve sepsis care and reduce
mortality outcome (O) from January 2018 to July 2018 (T).
Literature Review
A comprehensive electronic search was conducted in September 2017 reviewing
evidence that examined sepsis management and its impact on patient outcomes in the following
databases: Cochrane Database of Systemic Reviews, CINAHL Complete, and Pub Med. These
databases were searched using combinations of the following search terms: severe sepsis, sepsis
bundle, guidelines, sepsis screening. Limitations were set to include English only, peer-reviewed,
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research, systemic reviews, randomized controlled trials, and publication dates no earlier than
2009. The search yielded 63 articles. Articles were considered for inclusion if they included
severe sepsis and early identification/screening. Five articles specific to sepsis were selected for
review. The Research Evidence Appraisal Tool (Dang & Dearholt, 2017) was used to appraise
the evidence for this review. The appraisal tool (See Appendix G) includes criteria to evaluate
the strength and quality of the evidence. The articles were appraised to be a Level 5 due to the
fact that this is a quality improvement project. One article rated as high quality while the other
four articles rated as good quality. These articles were very useful as it provided the evidence
needed for this quality improvement project.
According to Mitchell (2013), cultural change occurs when new methods produce
desirable behavioral change and superior performance. As previously mentioned, guidelines for
early identification and treatment of sepsis has been known to decrease sepsis mortality by at
least 14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley, Sucher, Todd,
Turner, Valdivia, and Moore, 2009). Evidence-based practice (See Appendix B) has shown that
interventions such as the sepsis intermediate lactate bundle has proven to be an effective
treatment.
Rationale
While there are multiple methods of facilitating change at the organizational level, the
assistance of a change agent is necessary to assure that all efforts are purposeful, calculated, and
collaborative (Mitchell, 2013). According to Mitchell (2013), choosing a change theory for
change agents to use that will provide a framework for implementing, managing and evaluating
change is critical. Kotter’s 8-step Process for leading change provides an effective framework
for implementing the CNL’s change strategy. This eight-step process includes “establishing a

Improving Intermediate Lactate

7

sense of urgency, creating the guiding coalition, developing a vision and strategy,
communicating the change vision, empowering broad-based action, generating short-term wins,
consolidating gains and producing more change, and anchoring new approaches in the culture”
(Kotter, 1996).
Kotter’s eight-step process for change will be applied in the planning, development,
implementation and evaluation phases of this change strategy project. Like most EDs, this is a
fast-paced microsystem where changes occur constantly. Providing patient-centered care amid
constant change can be challenging and stressful at times. Therefore, even though the nurses are
accustomed to frequent change, it is imperative that process changes be implemented in a way
that is sensitive to the level of stress the nurses are experiencing. Also, it needs to be organized
in a way that will cause the least disruption in their ability to provide safe patient care. With this
in mind, Kotter’s eight-step process will guide the action plan for the implementation of this
change strategy and provide a systematic approach that will guide the primary change agent
through a series of actions that can lead to enhanced change outcomes. In addition, the model
for improvement framework will be used to test change ideas and determine if the change is an
improvement using the Plan-Do-Study-Act (PDSA) method (See Appendix L).
Specific Project Aim
To increase the percentage of patients with a documented elevated intermediate lactate
who receive intermediate lactate bundle interventions, from a baseline of 43% per month to 55%
per month by July 2018 with a primary focus on repeat lactate within 6 hours.
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Context
Microsystem Assessment
Understanding the microsystem is an important step toward improvement and provides
the opportunity to transform the delivery of care at the front line (Nelson, Batalden & Godfrey,
2007, p.6). Using the Dartmouth assessment tool provided a systematic and objective review of
the microsystem which focused on the 5 P’s: purpose, patients, professionals, processes, and
patterns. This tool helped gain a better understanding of the microsystem and provided baseline
information necessary to build a successful high functioning microsystem which is the building
block of all health care systems (Nelson, Batalden & Godfrey, 2007). The purpose of this
hospital revolves around “improving the health of our members and the communities we serve”.
The team works passionately to fulfill this promise by establishing processes that ensurepatient
safety and effective clinical care. They strive to deliver excellent care by reducing mortality,
length of stay, and complications through a multidisciplinary approach. The team believes that
collaboration with key stakeholders is a key component to success. There is significant number
of the Patient population seen and assessed that are from low-income communities. There has
been an increase in the number of patients served at this hospital who are uninsured and rely on
Medi-Cal for coverage of treatment and services. The professional team is comprised of, but not
limited to, ER physicians, an HBS physician, registered nurses, physician assistants, and other
ancillary staff. Supporting diagnostic departments are available as needed. Thirty-three percent
of the staff state that working in the unit is stressful. However, 76% of the staff state that they
would recommend their unit as a good place to work. The processes of patient care are focused
on patient stabilization and personalized treatment to fit every individual’s plan of care. The unit
has processes in place to ensure patient safety and excellent transition of care. In addition, the
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unit has a very engaged rapid response team and multidisciplinary team that rounds on patients
to discuss patient progress and discharge goals. The pattern consists of a multidisciplinary teambased approach to provide high-quality care that prioritized patient safety and satisfaction. There
is a monthly nurse quality forum in which representatives of the team participate in to discuss
clinical care issues. Also, there is a workgroup that meets monthly to discuss patient safety
issues or concerns. The unit team takes pride in involving the patients and family members in
their care. The team has gone through some challenges in the last year and a half with leadership
turnovers and staff shortage which has dampenend the morale of the team. However, they are
encouraged and optimistic about their new leadership and onboarding of new staff.
The SWOT analysis (See Appendix K) revealed that the strengths of this project included
improved patient outcome and standardization. The team’s commitment to provide exceptional
quality care and their openness to evidence-based practices that improve patient care are also
their strengths. An identified weakness is that, although there is a sepsis workgroup already in
existence, it was not effective. In addition, although the severe sepsis protocol has been
standardized, the nurses and providers still did not follow the process as outlined within the
bundle. There was also variation in the approach to sepsis identification and treatment which was
identified as an opportunity. Threats include insufficient education/training due to lack or
resources and time. Also, the potential for lack of interest and inconsistency by providers was
identified as a threat. This analysis was shared with the team during the kick-off meeting.
Based on data compiled on the number of sepsis alerts per month for this medical center,
the emergency department sees approximately 40-43 sepsis patients per month which equals to
about 1.3 to 1.4 patients a day. This equates to about 480 – 516 patients being treated each year
for sepsis at this facility and roughly estimates to 8.6 - 9.3 million dollars in sepsis treatment a
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year. By increasing compliance to the intermediate lactate bundle ensuring that the patient
receives the appropriate treatment according to the protocol, then the possibility of reducing the
average LOS by 3.2 days in the ICU alone can save the organization a staggering $1.7 million
per year (See Appendix F).
Intervention
To provide the best possible patient-centered care maximizing the overall health of our
members we needed to provide sepsis intermediate lactate bundle re-education for physicians,
nurses, lab and pharmacy personnel. In addition, evidence supported early identification of signs
and symptoms of severe sepsis by frontline nurses using a sepsis screening tool (Moore, Jones,
Kreiner, McKinley, Sucher, Todd, Turner, Valdivia, and Moore, 2009).
Changes that were implemented include: (1) a revised sepsis screening tool to help
frontline nurses recognize early signs of sepsis, (2) a sepsis alert protocol via an overhead page
to activate early and appropriate interventions, (3) a revised sepsis reminder time tool which
outlined timely appropriate treatment based on clinical guidelines for patients diagnosed with
sepsis, and (4) a standardized process between lab and nursing for repeat lactate orders. Data
collecting methods include chart reviews, observations, and the use of a survey to determine
compliance with use of the tools and processes as outlined.
Study of the Intervention
Evidence-based practice has shown that interventions such as the sepsis intermediate
lactate bundle have proven to be an effective treatment. Aiming for increased compliance in
following the sepsis bundle will result in reduced mortality, reduced readmission, reduced length
of stay, and reduced complications from sepsis, i.e. renal failure.
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Data was obtained from 100% retrospective medical record review of the patient records
for project measures per week from January – April 2018. Concurrent observations were
conducted when a sepsis alert was called to see if the sepsis screening tool was used for
identification of early signs of sepsis. In addition, an audit of the use of the sepsis reminder time
tool was performed each time a sepsis alert was called. Weekly email communication was sent
out to update the team on their progress. The PDSA cycle (See Appendix L) results were
evaluated every month at the sepsis workgroup meeting. Cycle 1 took a couple of weeks to
implement because we had to ensure that the sepsis alert was not only announced overhead but
that it also generated an automated message that was sent via text to designated team members
on their mobile phones as well as an automated call on their office work phones. These calls
made it very easy for staff to spring into action once they were notified or heard the sepsis alert.
Cycle 2 also took a couple of weeks because the staff determined that they needed to revise the
sepsis screening tool so that it was easier for all the staff to use. This was a very important step
since it was the team’s idea to revise the tool, it made it easier to get buy-in from all the staff.
The team had to go through the same process for the sepsis clock. The staff agreed that they
would rename it as a sepsis reminder time tool. Once both tools were revised and
implementation of the tools went very smoothly.
Measures
This project included an outcome measure which was to increase intermediate lactate
bundle compliance. Within this bundle, there are four process measures which include lactate
drawn within one hour of ED arrival, appropriate antibiotic administered within three hours of
ED arrival, fluids administered appropriately within three hours of ED arrival, and repeat lactate
drawn within six hours of ED arrival. Of these four elements, the one that this unit struggled
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the most with was the repeat lactate drawn within six hours of ED arrival. Therefore, the team
agreed that they would focus on this process measure as part of this improvement project.
Lastly, as a balancing measure, the team agreed to monitor if there would be an increase in
workload for laboratory staff causing delay in completing other lab orders as a result of this
project. Performance on these measures will be monitored with data displayed over time using
Statit graphs. Please see Appendix C for family of measures and measure definition.
Ethical Considerations
As an advocate, the CNL role provides an opportunity to address the concerns of
colleagues, providing a platform for discussion, providing opportunities to reinforce the
positives. Ethical considerations were taken to ensure that there was no unfair discrimination
based on age, gender, gender identity, race, ethnicity, culture, national origin, religion, sexual
orientation, disability, socioeconomic status, or any basis proscribed by law. In addition, steps
were taken to ensure there was no financial conflict of interest. The project was reviewed by
faculty and is determined to qualify as an Evidence-based Change in Practice Project, rather than
a Research Project. Institutional Review Board (IRB) review is not required (See Appendix A,
IRB Non-Research Determination Form). Lastly, Privacy and Confidentiality were taken into
consideration to build trust, to empower and influence teamwork, which is a critical piece in
bringing about change.
Results
Following initiation of the sepsis alert via overhead page in January, results show that
there was a total of 165 sepsis alerts called between January to April 2018. An audit of these
cases revealed that utilization of the sepsis screening tool and the sepsis time reminder tool
ranged from 65% to 90% (See Appendix J). In addition, results show that compliance with the
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use of the sepsis screening tool (See Appendix H) and sepsis time reminder tool (See Appendix
I) resulted in improved intermediate sepsis bundle performance starting in January (See
Appendix D). Performance in February continued to show improvement which was above the
target of 55%. Lastly, repeat lactate compliance also showed significant improvement after
standardizing a workflow process between lab and nursing for repeat lactate orders (See
Appendix F). This data suggests that consistent use of the sepsis screening tool and the sepsis
reminder time tool resulted in increased performance with the intermediate lactate bundle
compliance which evidence also suggest. Secondarily, there seems to be a correlation with the
improved repeat lactate performance and the improved intermediate lactate bundle performance
as shown in the graph.
Discussion
Summary
According to Mitchell (2013), cultural change occurs when new methods produce
desirable behavioral change and superior performance. The improvement in performance as
shown in Appendix D and Appendix F had it not been for the cultural shift within this unit. It
was not until the staff recognized the need for change and took ownership of the change process
that improvement occurred. The staff took the initiative to take the tools that were not working
for them and changed it so that they had a tool that was easier for the staff to use and developed
a process that was sustainable and not person dependent. Also, having the sepsis physician and
nurse champions who drove the process improvement efforts made a significant difference. So
far, current performance has been above target for the last 3 months which shows that the
interventions worked. As mentioned earlier, results from this project has the potential of
reducing the average LOS by 3.2 days for patients admitted in the ICU. This can potentially
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save the organization $1.7 million per year. In addition to the cost-saving factor for this
improvement project, an increase in patient satisfaction may also be obtained since patients are
able to go home sooner rather than later. Although this is only a soft dollar benefit, providing
the patient an excellent care experience is rewarding in and of itself. Ultimately, I believe this is
the greatest incentive for conducting a performance improvement project.
Conclusion
As mentioned earlier, the focus of this project is to improve intermediate lactate bundle
performance by providing tools to help nurses identify sepsis early and allowing treatment to be
started timely to achieve a better outcome for the patient. The CNL role is in a unique position
to reinforce change, and has been historically proven effective in facilitating changes in the
microsystem level, having a positive impact on patient outcomes (Stanley et al., 2008). Also, the
CNL functions as a quality manager who is skillful at identifying departmental needs and
championing cost-effective, evidence-based care within the microsystem which is vital to this
improvement project. While there were some delays in getting the project going, overall,
implementation of the sepsis screening tool and the sepsis reminder time tool and re-educating
the staff regarding the hospital’s sepsis protocol went very smoothly. The aim of the project was
achieved within the second month of implementation.
Emphasizing staff empowerment not only helped implement the change but it also helped
improve the unit environment. Utilizing sepsis nurse and physician champions to hardwire the
process was a critical factor for this project along with a cultural shift which resulted in increased
compliance to the intermediate lactate bundle and provided a strong possibility for sustainability.
In conclusion, I feel that this change strategy positively impacted the lives of our patients as well
as the overall health of the organization.
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Appendix A
CNL Project: Statement of Non-Research Determination Form
Title of Project:
Improving Sepsis Care by improving intermediate lactate bundle performance
Brief Description of Project:
One of the most significant problems we are facing today in healthcare, with an incidence of
300 to more than 1,000 cases per 100,000 persons annually in the United States, is severe
sepsis (Gaieski, Edwards, Kalian, & Carr, 2013). The number of critically ill patients
presenting in the ED with sepsis is staggering. According to Hall et al. (2011), the number
of patients in the hospital with a principal diagnosis of sepsis or septicemia has more than
doubled from 11.6 in 2000 to 24.0 in 2008 per 10,000 patients with mortality associated with
severe sepsis ranging at 30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011).
Guidelines for early identification and treatment of sepsis has been known to decrease sepsis
mortality by at least 14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley,
Sucher, Todd, Turner, Valdivia, and Moore, 2009).
A) Aim Statement:
To improve sepsis care by increasing compliance with the intermediate lactate bundle from
43% to 55% by July 2018.
B) Description of Intervention:
To provide the best possible patient-centered care maximizing the overall health of our
members, we need to provide Sepsis intermediate lactate bundle re-education for physicians,
nurses, lab and pharmacy personnel. In addition, evidence supports early identification of
signs and symptoms of severe sepsis by frontline nurses using a sepsis screening tool.
C) How will this intervention change practice?
Evidence based practice has shown that interventions such as the sepsis intermediate lactate
bundle has proven to be an effective treatment. Aiming for increased compliance in
following the sepsis bundle elements will result in reduced mortality, reduced readmission,
reduced length of stay, and reduced complications from sepsis.
D) Outcome measurements:
Outcome: Increased Sepsis Bundle compliance for Intermediate lactate
Process: Repeat Lactate Drawn within 6 hrs. of ED arrival
Balancing: Increase in workload for lab staff causing delay in completing other lab orders

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the
criteria outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)
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× This project meets the guidelines for an Evidence-based Change in Practice Project as outlined
in the Project Checklist (attached). Student may proceed with implementation.

☐This project involves research with human subjects and must be submitted for IRB approval
before project activity can commence.
Comments:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
Instructions: Answer YES or NO to each of the following statements:
Project Title: Improving Intermediate Lactate Sepsis Bundle Performance
The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There
is no intention of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and
is a part of usual care. ALL participants will receive standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
or group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case control). The project does NOT follow a protocol
that overrides clinical decision-making.
The project involves implementation of established and tested quality standards
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new untested standards.
The project involves implementation of care practices and interventions that
are consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of
colleagues, students and/ or patients.
If there is an intent to, or possibility of publishing your work, you and
supervising faculty and the agency oversight committee are comfortable with
the following statement in your methods section: “This project was undertaken

YES

NO

X

X
X

X

X

X
X
X

X

as an Evidence-based change of practice project at X hospital or agency and as
such was not formally supervised by the Institutional Review Board.”
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human
Research Committee, Partners Health System, Boston, MA.
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Appendix B
Study

Evaluation Table
Design
Sample

Outcome/Feasibility

Evidence rating

Amland, R. C., & HahnCover, K. E. (2016). Clinical
Decision Support for Early
Recognition of Sepsis.
American Journal of Medical
Quality, 31(2), 103–110.

Quality
Improvement
using
retrospective
cohort design

817 Patients
were segmented
into one of 3
cohorts based on
intervals
between first
alert activation
and initial orders
for diagnostics
and
interventions.

Provides guidelines
for cloud-based
sepsis CDS.
Integrated with
enterprise EHR
systems can be an
effective approach
toward early
recognition of sepsis
in a hospital setting.

LVA

Drahnak, D. M. (2016).
Scripting Nurse
Communication to Improve
Sepsis Care.

Quality
Improvement
project using
pre- & postsurvey design

Conducted in a
648-bed Level 1
trauma hospital
using a
randomized
sample involving
681 nurses.

Provides a strong
foundation on which
to build an interprofessional
organizational sepsis
treatment program.

LVB

Gaieski, D., Edwards, J.,
Kallan, M., Carr, B.
Benchmarking the incidence
and mortality of severe sepsis
in the United States. Crit Care
Med. 2013;41(5):1167-1174.

Case
presentation

none

A uniform,
LVB
consistent method is
needed for use in
national registries to
facilitate accurate
Benchmarking the
Incidence and Morta
assessment of
clinical interventions
and outcome
comparisons between
hospitals and
regions.

Moore, L., Jones, S., Kreiner,
L., McKinley, B., Sucher, J.,
Todd, S., Turner, K., Valdivia,
A., Moore, F. (2009).
Validation of a sepsis
screening tool for the early
identification of sepsis. The
Journal of Trauma, Infection,
and Critical Care, 66(6), 15391547

Quality
Improvement
retrospective
observational
design

Conducted 4,991
sepsis screens on
920 patients
representing 927
ICU admissions.

Implementation of
this tool and logicbased sepsis protocol
has decreased sepsisrelated mortality.
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Case
presentation

None

Through formal,
LVA
standardized
education programs,
and nationally
recognized role
The Clinical Nurse
leader. a catalyst for
competencies and
expectations, the
CNL represents a
promising
opportunity for
nursing to take a
leadership role in
implementing quality
improvement and
patient safety
initiatives across all
health care settings.

Ramsdell, T.H., Smith, A.N.,
and Kerkhove, E. (2017).
Compliance with Updated
Sepsis Bundles to Meet New
Sepsis Core Measure in a
Tertiary Care Hospital

Quality
Improvement
retrospective
cohort design

Conducted in
158 patients with
a diagnosis of
severe sepsis or
septic shock
from April 2015
to February
2016.

Increased adherence
to the care bundles
may improve inhospital survival.
Implementation of
BPA messages
allows for rapid
identification of
sepsis and provides
for immediate access
to checklists and
order sets for timely
initiation of
appropriate
treatment.
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Appendix C
Project Charter
Project Charter:
Improving Sepsis Care by improving intermediate lactate bundle performance.
Global Aim:
To reduce Severe Sepsis (lactate 2-4) mortality from 7.8% to 5.3%.
Specific Aim:
To improve sepsis care by increasing compliance with the intermediate lactate bundle from 43%
to 55% by July 2018.
Background:
One of the most significant problems we are facing today in healthcare, with an incidence of 300
to more than 1,000 cases per 100,000 persons annually in the United States, is severe sepsis
(Gaieski, Edwards, Kalian, & Carr, 2013). The number of critically ill patients presenting in the
ED with sepsis is staggering. According to Hall et al. (2011), the number of patients in the
hospital with a principal diagnosis of sepsis or septicemia has more than doubled from 11.6 in
2000 to 24.0 in 2008 per 10,000 patients with mortality associated with severe sepsis ranging at
30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011). Guidelines for early
identification and treatment of sepsis has been known to decrease sepsis mortality by at least
14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley, Sucher, Todd, Turner,
Valdivia, and Moore, 2009). Evidence based practice has shown that interventions such as the
sepsis intermediate lactate bundle has proven to be an effective treatment. This hospital’s
performance has been well below the target of 55% for intermediate lactate for at least 9 out of
12 months this past year. Performance were at times 35 percentage points lower than target. As
a result, this medical center is one of the lowest performers in the region when it comes to sepsis
care. Therefore, the aim of this project is to increase intermediate lactate bundle compliance by
12% from 43% to 55% by July 2018.
Goals:
To provide the best possible patient-centered care maximizing the overall health of our members
by providing:
1. Sepsis intermediate lactate bundle education for physicians, nurses, lab and pharmacy
personnel.
2. Early identification of signs and symptoms of severe sepsis.

Improving Intermediate Lactate
Family of Measures
Measure
Outcome
Increased Sepsis Bundle
compliance for Intermediate
lactate
Process
Lactate drawn within 1 hr. of
ED arrival
Appropriate antibiotic
administered within 3 hrs. of
ED arrival
Fluids administered
appropriately within 3 hrs. of
ED arrival
Repeat lactate drawn within 6
hrs. of ED arrival
Balancing
Increase in workload for lab
staff causing delay in
completing other lab orders

Data Source

Target

Statit

55%

Chart Review - KPHC

95%

Chart Review - KPHC

95%

Chart Review - KPHC

95%

Chart Review - KPHC

95%

Chart Review - KPHC

5%

Sponsors
Chief Nursing Executive
Area Quality Leader

Shanthi Margoschis
Jerry Grandon

Team Members
ED physician champion
ED nurse champion
ED educator
ICU physician champion
ICU nurse champion
ICU educator
Laboratory
Radiology
Pharmacy
Quality nurse (CNL)

Dr. Stephanie Zarfoss
Tanisha Jimenez/Theresa Garrett
Mia Alcavala
Dr. Theodore Fong
Quyen Nguyen
Terry Olson
Roniel Duquez
Tom Lansburg
Kelsea Kerr
Jocelyn Alimboyoguen
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Measurement Strategy
Population Criteria:
All inpatients with Sepsis diagnosis present on admission and a lactic acid >=2 in ED
Data Collection Method:
Data will be obtained from retrospective medical record review of patient records for project
measures per week from January – July 2018. Data plan will be reevaluated q month based on
results.
Data Definitions
Data Element
Sepsis
SIRS (Systemic Inflammatory Response
Syndrome)

Severe Sepsis

Definition
SIRS plus clinical suspicion of infectious etiology
Requires 2 of the 5 criteria:
- Temperature <36 degrees C or >38 degrees C
- Heart rate >90 beats per minute
- Respiratory rate >20 breaths per minute or
PaCO2 <32 mm Hg
- WBC <4,000/cubic mm or >12,000/cubic mm or
Greater than 10% bands on differential
- Altered mental status
Sepsis and any of the following that are
attributable to infection:
- Intermediate lactate level (2 to 3.9 mmol/L)
- Any systolic blood pressure reading below 90
mm Hg
- Any single MAP less than 65 mm HG
- Systolic blood pressure >40 mm HG below
patient baseline
- Organ dysfunction regardless of lactate level,
defined as: hypoxia or mechanical ventilation,
delirium, creatinine >20mg/dL, bilirubin >
2mg/dl, platelet count <100,000, INR >1.5 or
aPTT >60 sec.

Improving Intermediate Lactate
Measure Description
Measure

Measure Definition

Sepsis Intermediate
N=# cases that met
Lactate Bundle - % of each element of the
compliance
bundle
D=# total number of
cases that met severe
sepsis criteria
% of patients with
N= # patients with
lactate drawn within
lactate w/in 1 hr
1 hr. of ED arrival
D= # patients with
lactate drawn
% patients given
N= # patients given
antibiotics w/in 3
antibiotics w/in 3 hrs
hours
D=# patients given
antibiotics for sepsis
% patients given
N= # patients given
fluids w/in 3 hours
fluids w/in 3 hrs
D=# patients given
fluids for sepsis
% of patients with
N= # patients with
repeat lactate drawn
lactate w/in 6 hrs
within 6 hrs
D= # patients with
lactate drawn

Data Collection
source
Chart audit

Goal

Infoview report
Chart audit-

100%

Infoview report
Chart audit

100%

Infoview report
Chart audit

100%

Infoview report
Chart audit-

100%

100%
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Driver Diagram
AIM

PRIMARY
DRIVERS

SECONDARY
DRIVERS
Communication between
MD and colleagues

Relationship-based Care

Improve warm hand-off
between ED and ICU
Improve communication
between lab and nursing

Standardized lab collection
processes
To improve sepsis care by
increasing compliance
with the intermediate
lactate bundle from 43%
to 55% by July 2018

Evidence-based Practice

Standardized procedure
nurse draw of repeat lactic
acid
Educational inservice
related to sepsis care

Standardized warm
hand-off
Care Coordination
Establish nurse draw vs.
lab draw
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Recommendations for Changes
1. Develop Sepsis screening tool to help frontline nurses recognize early signs of Sepsis.
2. Develop a standardized process between lab and nursing for repeat lactate orders.
3. Develop a system for timely reassessment of patient diagnosed with sepsis.
Project Timeline
Kotter’s Change
Model
Tasks

Creating a change
climate

Engaging & enabling others

Implementing & sustaining
change

Week Week Week Week Week Week Week Week Week Week Week
1
2
3
4
5
6
7
8
9
10
11

Week
12 - 24

Microsystem
Assessment
Develop Aim
Identify team
Sepsis Workgroup
meetings
Develop project charter
Staff interview
Develop training plan
Staff Education &
training
Observe Sepsis alerts
Chart audit for
compliance with bundle
Attend staff in-service
meetings
Address any
outstanding issues

Lessons Learned
1. Identified that there is a sepsis workgroup already in existence but not effective
2. Identified that there is variation in the approach to sepsis identification and treatment
3. Gaps in sepsis care specifically around patient reassessment
4. Lack of warm hand off between departments i.e. lab and nursing, ED staff and ICU staff

Ongoing
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CNL Competencies
The CNL as defined by the American College in Nursing is “a master’s educated nurse,
prepared for practice across the continuum of care within any healthcare setting”
(“American Association of Colleges of Nursing | Clinical Nurse Leader (CNL),” n.d.). They
also implement evidence-based practice in all healthcare settings. CNLs educate individuals,
families, groups, and other health care providers. They lead in clinical decision making, and
they oversee care delivery and outcomes. (Harris, Roussel, & Thomas, 2014)
The CNL role is in a unique position to reinforce change, and has been historically proven
effective in facilitating changes at a microsystem level, having a positive impact on patient
outcomes (Stanley et al., 2008). As a team leader and a team member, the CNL functions as a
leader within the microsystem and a quality manager, proficient with interdepartmental, and
interdisciplinary communication, while being skillful at identifying departmental needs and
championing cost effective, evidence based care within the microsystem (Wienand, et al., 2015).
As a member of a profession, bound by the ongoing challenge to effect positive change in health
care practice and outcomes, the CNL has a large skill set to draw upon (American Association of
Colleges of Nursing, 2017). As an advocate, the CNL role provides an opportunity to address the
concerns of colleagues, providing a platform for discussion, providing opportunities to reinforce
the positives. Additionally, through incorporating the role of an educator where there may be a
lack of clarity, the CNL can also encourage team members to address their concerns and initiate
discussion. The CNL’s ability to facilitate working relationships within the microsystem while
developing a successful implementation of sepsis care interventions in the ICU setting can
further enhance the care provided to the patient. Ultimately, our shared agenda is to provide the
best care possible for our patients.

Improving Intermediate Lactate
Appendix D
Intermediate Lactate Bundle Compliance
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Repeat Lactate Compliance
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Appendix F
Estimated Cost of Business Plan
Staff

Hour/Unit

Hourly Rate

Final Cost

RN champion salary

4 hrs./wk x 24 wks
= 96 hours

$75.00

$7,200

Lab champion salary

4 hrs./wk x 24 wks
= 96 hours

$50.00

$4,800

Educator champion salary

4 hrs./wk x 24 wks
= 96 hours

$75.00

$7,200

Office Supplies (copy paper, chart
pads, markers, highlighter, pens)

$800

Educational Materials (badge cards,
etc.)

$2,000

Total Operating Expenses:

$200.00

$22,000

12-month impact

Key Assumptions

Approx. $18,000
per case –
Projecting
reduction of 4.7
days per case
(516 cases/year):
$4,850,400/year

Severe Sepsis rates for
one year will follow
trend of
Jul – Nov 16
Average hospital cost
of $6,000/day

Projected Savings
Hard Financial Benefit
Decrease hospital days by average of
4.7 days
Jul – Nov 16 average LOS:
Target not met: 9 days
Target met: 4.3 days

52% reduction

Decrease ICU LOS by average of 3.2
days ($2000 average per day) Jul –
Nov 16 average LOS:
Target not met: 6 days
Target met: 2.8 days

53% reduction

Averted ICU Admissions

Total Savings:

10%

Approx. $6,000 per Severe Sepsis rates for
case – Projecting
one year will follow
reduction of 3 days
trend of
per case
Jul – Nov 16
(516 cases/year):
Average hospital cost
$1,651,200/year
of $2,000/day
Approx. 100 cases
would be averted
with avg. hospital
LOS of 5 days:
$1,000,000/year

$7,501,000

Based on screening
eligibility for severe
sepsis care and not
meeting criteria:
Average ICU LOS
$2,000/day over regular
hospital bed for 5 days
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Number of alerts

Sepsis alerts
70
60
50
40
30
20
10
0
Jan-18

Feb-18

Mar-18

Apr-18

Month

Sepsis screening tool usage
Percentage of usage

100%
80%
60%
40%
20%
0%
Jan-18

Feb-18

Mar-18

Apr-18

Month

Sepsis clock usage
Percentage of usage

100%
80%
60%
40%
20%
0%
Jan-18

Feb-18

Mar-18

Month

Apr-18
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Appendix K
•Evidence-based
•Great Teamwork
•Commitment to provide
quality care

•Leverging technology to
identify septic patients

Strengths

Weakness

Opportunities

Threats

Inconsistent hand-off between
nursing and lab
•No standard hand-off
template
•Lack of leadership
•Insufficient education/
training
•Interruptions during care

Cost
•Alert fatigue
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